Stockscreener 앱 받기
92.73
0.72%
-0.67
전일 마감가:
$93.40
열려 있는:
$92.69
하루 거래량:
924.24K
Relative Volume:
0.74
시가총액:
$10.76B
수익:
$2.77B
순이익/손실:
$286.61M
주가수익비율:
39.46
EPS:
2.35
순현금흐름:
$524.11M
1주 성능:
+2.15%
1개월 성능:
+1.74%
6개월 성능:
+1.88%
1년 성능:
-20.09%
1일 변동 폭
$91.39
$93.54
1주일 범위
$91.03
$95.79
52주 변동 폭
$81.36
$128.28
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
RVTY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
92.73 | 10.59B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
578.71 | 217.96B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.21 | 156.24B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
689.93 | 56.01B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.82 | 41.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
220.61 | 38.07B | 15.90B | 1.28B | 2.21B | 7.2842 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-16 | 개시 | Guggenheim | Neutral |
| 2025-05-01 | 업그레이드 | UBS | Neutral → Buy |
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Why Revvity Inc. is moving todayPortfolio Value Report & Safe Entry Trade Signal Reports - newser.com
Can Revvity Inc. stock sustain institutional flowsPortfolio Value Report & Verified Short-Term Trading Plans - newser.com
Can Revvity Inc. stock sustain breakout momentumTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
Why analysts remain bullish on Revvity Inc. stock2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Why Revvity Inc. stock remains stableJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
What Fibonacci levels say about Revvity Inc. rebound2025 Performance Recap & Growth-Oriented Investment Plans - newser.com
Is Revvity Inc. (PKN) stock included in top ETFsJuly 2025 Earnings & Safe Capital Growth Tips - newser.com
Is Revvity Inc. stock dividend growth reliableMarket Trend Summary & High Conviction Buy Zone Alerts - newser.com
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more - MSN
Key deals this week: Merck, Day One Biopharmaceutical, ABN AMRO, Revvity, Centerspace and more (BX:NYSE) - Seeking Alpha
Relative strength of Revvity Inc. in sector analysisWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Pattern recognition hints at Revvity Inc. upside2025 Retail Activity & Accurate Buy Signal Notifications - newser.com
How Revvity Inc. stock reacts to fiscal policiesJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - newser.com
Why Revvity Inc. stock remains a top recommendation2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com
What earnings revisions data tells us about Revvity Inc.Trade Ideas & AI Optimized Trading Strategy Guides - newser.com
Can Revvity Inc. stock withstand economic slowdownMarket Volume Report & Capital Efficient Trading Techniques - newser.com
Why Revvity Inc. stock could see breakout soonWeekly Trade Recap & Verified Swing Trading Watchlists - newser.com
Developing predictive dashboards with Revvity Inc. dataJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Can trapped investors hope for a rebound in Revvity Inc.Trade Entry Summary & Detailed Earnings Play Strategies - newser.com
Is Revvity Inc. (PKN) stock safe for risk averse investorsSwing Trade & Accurate Intraday Trading Signals - newser.com
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.34%
0.03%
자본화:
|
볼륨(24시간):